VOYA INVESTMENT MANAGEMENT LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 189 filers reported holding MYRIAD GENETICS INC in Q4 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$842,004
-30.3%
52,494
+0.7%
0.00%0.0%
Q2 2023$1,208,883
+2.7%
52,152
+3.0%
0.00%
-50.0%
Q1 2023$1,176,716
+51.3%
50,655
-5.5%
0.00%
+100.0%
Q4 2022$777,620
-36.4%
53,592
-16.3%
0.00%
-50.0%
Q3 2022$1,221,788
+5.0%
64,0350.0%0.00%
-33.3%
Q2 2022$1,164,000
-28.5%
64,035
-0.9%
0.00%0.0%
Q1 2022$1,629,000
-8.1%
64,629
+0.6%
0.00%0.0%
Q4 2021$1,773,000
+0.5%
64,259
+17.5%
0.00%
-25.0%
Q3 2021$1,765,000
+8.0%
54,669
+2.3%
0.00%
+33.3%
Q2 2021$1,634,000
+21.4%
53,425
+20.9%
0.00%0.0%
Q1 2021$1,346,000
+54.0%
44,204
+0.1%
0.00%
+50.0%
Q4 2020$874,000
+75.9%
44,180
+15.9%
0.00%
+100.0%
Q3 2020$497,000
+14.3%
38,119
-0.7%
0.00%0.0%
Q2 2020$435,000
-37.7%
38,386
-21.4%
0.00%
-50.0%
Q1 2020$698,000
-55.3%
48,808
-15.0%
0.00%
-33.3%
Q4 2019$1,563,000
+6.2%
57,400
+11.6%
0.00%0.0%
Q3 2019$1,472,000
+2.6%
51,426
-0.4%
0.00%0.0%
Q2 2019$1,434,000
-17.5%
51,621
-1.4%
0.00%
-25.0%
Q1 2019$1,738,000
+11.3%
52,350
-2.6%
0.00%0.0%
Q4 2018$1,562,000
-34.8%
53,736
+3.3%
0.00%
-20.0%
Q3 2018$2,394,000
+23.1%
52,0360.0%0.01%
+25.0%
Q2 2018$1,945,000
+22.5%
52,036
-3.2%
0.00%
+33.3%
Q1 2018$1,588,000
+15.5%
53,744
+34.2%
0.00%0.0%
Q4 2017$1,375,000
+23.1%
40,043
+29.7%
0.00%
+50.0%
Q3 2017$1,117,000
+40.2%
30,8620.0%0.00%0.0%
Q2 2017$797,000
+46.0%
30,862
+8.5%
0.00%
+100.0%
Q1 2017$546,000
+15.2%
28,4530.0%0.00%0.0%
Q4 2016$474,000
-22.9%
28,453
-4.8%
0.00%0.0%
Q3 2016$615,000
-32.8%
29,8900.0%0.00%
-50.0%
Q2 2016$915,000
-18.2%
29,8900.0%0.00%
-33.3%
Q1 2016$1,119,000
-13.3%
29,8900.0%0.00%0.0%
Q4 2015$1,290,000
+15.2%
29,8900.0%0.00%0.0%
Q3 2015$1,120,000
-0.9%
29,890
-10.1%
0.00%0.0%
Q2 2015$1,130,000
-8.1%
33,235
-4.3%
0.00%0.0%
Q1 2015$1,230,000
+3.5%
34,744
-0.4%
0.00%0.0%
Q4 2014$1,188,000
-16.3%
34,899
-5.2%
0.00%0.0%
Q3 2014$1,420,000
-1.6%
36,816
-0.7%
0.00%0.0%
Q2 2014$1,443,000
+8.3%
37,075
-4.9%
0.00%0.0%
Q1 2014$1,332,000
+52.8%
38,969
-6.3%
0.00%
+50.0%
Q4 2013$872,000
-11.6%
41,586
-0.9%
0.00%0.0%
Q3 2013$986,000
-89.6%
41,978
-88.1%
0.00%
-92.3%
Q2 2013$9,443,000351,4160.03%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders